| ELK.No | ES8845 |
| Product name | TNFAIP8L3 rabbit pAb |
| Reactivity | Human;Rat;Mouse |
| Applications | WB;ELISA |
| Other name | Tumor necrosis factor alpha-induced protein 8-like protein 3 (TNF alpha-induced protein 8-like protein 3) (TNFAIP8-like protein 3) |
| Size | 50μL |
| Unit price ($) | 148 |
| Human gene ID | 388121 |
| Human Swiss-Prot | Q5GJ75 |
| Source | Rabbit |
| Isotype | IgG |
| Target | TNFAIP8L3 |
| Fields | |
| Gene name | TNFAIP8L3 |
| Protein name | TNFAIP8L3 |
| Human gene link | View Human Gene |
| Human Swiss link | View Human Swiss-Prot |
| Mouse gene ID | 244882 |
| Mouse gene link | |
| Mouse Swiss-Prot | Q3TBL6 |
| Mouse Swiss link | View Mouse Swiss-Prot |
| Rat gene ID | |
| Rat gene link | |
| Rat Swiss-Prot | |
| Rat Swiss link | |
| Immunogen | Synthesized peptide derived from human TNFAIP8L3. at AA range: 15-45 |
| Specificity | This antibody detects endogenous levels of TNFAIP8L3 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Clonality | Polyclonal |
| Dilution | WB 1:500-2000, ELISA 1:10000-20000 |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration | 1 mg/ml |
| Storage stability | -20°C/1 year |
| Molecular Weight (Da) | |
| Observed band (KD) | 33kD |
| Background | caution:It is uncertain whether Met-1 or Met-89 is the initiator.,similarity:Belongs to the TNFAIP8 family., |
| Function | caution:It is uncertain whether Met-1 or Met-89 is the initiator.,similarity:Belongs to the TNFAIP8 family., |
| Subcellular location | Cytoplasm . Cell membrane . On PDGF activation, translocates from cytoplasm to plasma membrane. . |
| Expression | Widely expressed (at protein level) (PubMed:25479791). Highly expressed in most carcinoma cell lines (PubMed:25479791, PubMed:25242044). |

Use collapsible tabs for more detailed information that will help customers make a purchasing decision.
Ex: Shipping and return policies, size guides, and other common questions.